Position in GANX
as of Sep 30, 2026
· filed Oct 7, 2026
Position Value
$23,355
-$47,695 QoQ
Shares Held
13,500
-61.4% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Dec 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Sep 30, 2026BENEDICT FINANCIAL ADVISORS INC holds $23,355 across 1 Biotechnology name. GANX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GANX |
Gain Therapeutics, Inc.
This page
|
13,500 | $23,355 |
All Filings in GANX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $23,355 | 13,500 | Shares | Sole | 2026-10-07 | |
| 2026-06-30 | $71,050 | 35,000 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $30,070 | 15,500 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $122,360 | 38,000 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $61,950 | 35,000 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $40,500 | 22,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $34,380 | 18,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $34,560 | 16,000 | Shares | Sole | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||